Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Inhibits the Progression of Group B Streptococcal Arthritis

Glucuronoxylomannan (GXM), the principal constituent of the Cryptococcus neoformans capsule, modulates the inflammatory response of human monocytes in vitro. Here we examine the efficacy of GXM as a novel anti-inflammatory compound for use against experimental septic arthritis. Arthritis was induced...

Description complète

Détails bibliographiques

Publié dans:	Infect Immun
Auteurs principaux:	Tissi, Luciana, Puliti, Manuela, Bistoni, Francesco, Mosci, Paolo, Kozel, Thomas R., Vecchiarelli, Anna
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2004
Sujets:	Molecular Pathogenesis
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC523051/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15501766/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.72.11.6367-6372.2004
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!